INAB IN8bio, Inc. - Common Stock
$1,14
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 6, 2026
52 Haftlık Aralık
$1–$3
14% of range
Analist Derecelendirmesi
BUY
10 analysts
Fiyat Hedefi
$6
+448% upside
P/E (TTM)
-0.3
ROE
-90.8%
Net Kâr Marjı
—
INAB Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.14
Piyasa Değeri
$11M
P/E (TTM)
-0.3
EPS (TTM)
$-4.44
Gelir (TTM)
—
Temettü Verimi
—
ROE
-90.8%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $3
INAB Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-4.44
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
INAB
Akran Ortalaması
P/E (TTM)
-0.3
—
P/B (F/D)
0.4
0.9
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
INAB
Akran Ortalaması
ROA
-73.0%
-74.6%
ROE
-90.8%
-92.1%
ROIC
-70.5%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
INAB
Akran Ortalaması
Current Ratio (Cari Oran)
8.8
2.7
Quick Ratio (Cari Oran)
8.6
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
INAB
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
INAB
Akran Ortalaması
INAB Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
10 analist
- Güçlü Al 2 20,0%
- Al 7 70,0%
- Tut 1 10,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
4 analist · 2026-08-19
Medyan
$5.50
Ortalama
$6.25
← Tüm hedeflerin altında
$1.14
Düşük
$4.00
Yüksek
$10.00
Medyan hedef
$5.50
+382,5%
Ortalama hedef
$6.25
+448,2%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.28%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.25 | $-0.38 | 0.13% |
| 31 Mart 2026 | $-0.26 | $-0.70 | 0.44% |
| 31 Aralık 2025 | $-0.45 | $-0.63 | 0.18% |
| 30 Eylül 2025 | $-0.85 | $-1.25 | 0.40% |
| 30 Haziran 2025 | $-1.24 | $-1.84 | 0.60% |
| 31 Mart 2025 | $-2.10 | $-2.04 | -0.06% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| INAB | $23M | -0.5 | — | — | -90.8% | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
| OSRH | — | — | — | — | — | — |
| LSTA | — | -1.0 | -83.0% | — | — | — |
| BIVI | — | — | — | — | — | — |
| LNAI | $513M | -2.7 | — | — | -586.4% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $17M | $17M | $14M | $7M | $5M | |
| SG&A Expense | $10M | $13M | $14M | $14M | $7M | $3M | |
| Operating Expenses | $20M | $31M | $30M | $29M | $15M | $9M | |
| Operating Income | $-19M | $-30M | $-30M | $-29M | $-15M | $-9M | |
| Interest Income | $421.0K | $230.0K | $0 | · | · | · | |
| Pretax Income | $-19M | $-31M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $-30M | $-30M | $-29M | $-15M | $-9M | |
| EPS (Basic) | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 | · | |
| EPS (Diluted) | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 | · | |
| Shares (Basic) | 4,374,328 | 1,784,890 | 29,864,932 | 20,967,955 | 9,969,733 | · | |
| Shares (Diluted) | 4,374,328 | 1,784,890 | 29,864,932 | 20,967,955 | 9,969,733 | · | |
| EBITDA | $-19M | · | $-30M | $-29M | $-15M | · |
Bilanço 20
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $11M | $21M | $18M | $37M | $18M | |
| Prepaid Expense | $788.0K | $1M | $3M | $4M | $2M | $150.0K | |
| Other Current Assets | $259.0K | $298.0K | $270.0K | $232.0K | $52.0K | $0 | |
| Current Assets | $28M | $13M | $25M | $22M | $39M | $18M | |
| PP&E (Net) | $2M | $3M | $4M | $4M | $97.0K | $186.0K | |
| PP&E (Gross) | · | · | · | · | $443.0K | $443.0K | |
| Accum. Depreciation | $3M | $2M | $1M | $321.0K | $346.0K | $257.0K | |
| Other Non-current Assets | $146.0K | $275.0K | $255.0K | $255.0K | $158.0K | $0 | |
| Total Assets | $32M | $21M | $34M | $33M | $42M | $21M | |
| Accounts Payable | $309.0K | $389.0K | $924.0K | $2M | $395.0K | $620.0K | |
| Accrued Liabilities | $2M | $1M | $3M | $2M | $1M | $2M | |
| Current Liabilities | $3M | $3M | $5M | $6M | $2M | $3M | |
| Capital Leases | $2M | $3M | $3M | $4M | $2M | $0 | |
| Total Liabilities | $5M | $6M | $9M | $10M | $4M | $3M | |
| Common Stock | $10.0K | $7.0K | $4.0K | $3.0K | $2.0K | $1.0K | |
| Paid-in Capital | $169M | $136M | $116M | $84M | $71M | $1M | |
| Retained Earnings | $-141M | $-122M | $-91M | $-61M | $-33M | $-18M | |
| Stockholders' Equity | $28M | $14M | $25M | $23M | $-38M | $-17M | |
| Liabilities + Equity | $32M | $21M | $34M | $33M | $42M | $21M | |
| Shares Outstanding | 9,766,132 | 2,416,066 | 43,287,325 | 24,545,157 | 18,781,242 | 3,764,488 |
Nakit Akışı 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $5M | $4M | $3M | $2M | $357.0K | |
| Deferred Tax | $-2M | $-6M | $-6M | $-5M | $-5M | $-3M | |
| Operating Cash Flow | $-13M | $-24M | $-23M | $-24M | $-14M | $-7M | |
| Investing Cash Flow | $0 | $-187.0K | $-600.0K | $-4M | $-309.0K | $0 | |
| Stock Issued | $9M | $4M | $14M | $10M | $36M | $499.0K | |
| Net Stock Activity | $9M | · | $14M | $10M | $36M | · | |
| Financing Cash Flow | $29M | $14M | $27M | $9M | $33M | $25M | |
| Net Change in Cash | $16M | $-10M | $3M | $-19M | $19M | $17M |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -73.0% | · | -89.9% | -75.8% | -46.4% | · | |
| ROE | -90.8% | · | -140.6% | -109.1% | -36.1% | · | |
| ROIC | -70.5% | · | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.8 | · | 4.6 | 3.8 | 17.3 | · | |
| Quick Ratio | 8.6 | · | 3.9 | 3.1 | 16.4 | · |
Değerleme (TTM) 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-30M | $-30M | $-29M | $-15M | · | |
| Market Cap | $23M | · | $1.79B | $1.70B | $2.47B | · | |
| P/E | -0.5 | -0.5 | -41.4 | -51.0 | -89.6 | · | |
| P/B | 0.8 | · | 71.9 | 74.8 | 64.8 | · | |
| P / Tangible Book | 0.8 | 38.6 | 71.9 | 74.8 | · | · | |
| P / Cash Flow | -1.8 | · | -76.8 | -70.5 | -183.1 | · | |
| Earnings Yield | -189.7% | -221.1% | -2.4% | -2.0% | -1.1% | · |
Gelir Tablosu 11
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $3M | $2M | $2M | $3M | $4M | $3M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| SG&A Expense | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $4M | $3M | |
| Operating Expenses | $5M | $5M | $5M | $4M | $5M | $6M | $6M | $7M | $9M | $9M | $8M | $7M | $8M | $8M | $8M | $7M | |
| Operating Income | $-5M | $-5M | $-5M | $-4M | $-5M | $-6M | $-6M | $-7M | $-9M | $-9M | $-8M | $-7M | $-8M | $-8M | $-8M | $-7M | |
| Interest Income | $154.0K | $176.0K | $91.0K | $113.0K | $107.0K | $110.0K | $64.0K | $23.0K | $60.0K | $83.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-5M | $-5M | $-5M | $-4M | $-5M | $-6M | $-6M | $-7M | $-9M | $-9M | $-8M | $-7M | $-8M | $-8M | $-8M | $-7M | |
| EPS (Basic) | $-0.25 | $-0.26 | $-2.28 | $-0.85 | $-1.24 | $-2.16 | $-6.85 | $-4.49 | $-5.51 | $-0.20 | $-0.20 | $-0.23 | $-0.27 | $-0.30 | $-0.31 | $-0.34 | |
| EPS (Diluted) | $-0.25 | $-0.26 | $-2.28 | $-0.85 | $-1.24 | $-2.16 | $-6.85 | $-4.49 | $-5.51 | $-0.20 | $-0.20 | $-0.23 | $-0.27 | $-0.30 | $-0.31 | $-0.34 | |
| Shares (Basic) | 19,467,091 | 19,467,114 | -87,764,633 | 4,537,683 | 4,119,153 | 2,575,325 | -44,646,749 | 1,577,363 | 1,566,951 | 43,287,325 | -54,885,777 | 31,545,783 | 28,472,346 | 24,732,580 | -38,322,815 | 21,661,544 | |
| Shares (Diluted) | 19,467,091 | 19,467,114 | -87,764,633 | 4,537,683 | 4,119,153 | 2,575,325 | -44,646,749 | 1,577,363 | 1,566,951 | 43,287,325 | -54,885,777 | 31,545,783 | 28,472,346 | 24,732,580 | -38,322,815 | 21,661,544 | |
| EBITDA | $-5M | $-5M | · | $-4M | $-5M | $-6M | · | $-7M | $-9M | $-9M | · | $-7M | $-8M | $-8M | · | $-7M |
Bilanço 19
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $22M | $27M | $11M | $13M | $12M | $11M | $4M | $10M | $13M | $21M | $13M | $17M | $11M | $18M | $28M | |
| Prepaid Expense | $540.0K | $721.0K | $788.0K | $1M | $515.0K | $837.0K | $1M | $3M | $2M | $3M | $3M | $4M | $2M | $4M | $4M | $2M | |
| Other Current Assets | $364.0K | $395.0K | $259.0K | $346.0K | $367.0K | $427.0K | $298.0K | $177.0K | $529.0K | $539.0K | $270.0K | $262.0K | $277.0K | $601.0K | $232.0K | · | |
| Current Assets | $18M | $23M | $28M | $12M | $14M | $13M | $13M | $7M | $13M | · | $25M | $17M | $19M | $14M | $22M | $30M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $350.0K | |
| Accum. Depreciation | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $807.0K | $564.0K | $321.0K | $417.0K | |
| Other Non-current Assets | $102.0K | $129.0K | $146.0K | $169.0K | $275.0K | $275.0K | $275.0K | $324.0K | $320.0K | · | $255.0K | $255.0K | $255.0K | $255.0K | $255.0K | $231.0K | |
| Total Assets | $22M | $26M | $32M | $17M | $19M | $20M | $21M | $16M | $22M | · | $34M | $26M | $30M | $25M | $33M | $38M | |
| Accounts Payable | $444.0K | $449.0K | $309.0K | $204.0K | $379.0K | $575.0K | $389.0K | $1M | $1M | · | $924.0K | $748.0K | $585.0K | $870.0K | $2M | $1M | |
| Accrued Liabilities | $761.0K | $681.0K | $2M | $418.0K | $635.0K | $1M | $1M | $769.0K | $2M | $895.0K | $3M | $2M | $2M | $1M | $2M | $3M | |
| Current Liabilities | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $5M | · | $5M | $5M | $4M | $4M | $6M | $5M | |
| Capital Leases | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | |
| Total Liabilities | $3M | $3M | $5M | $4M | $4M | $6M | $6M | $7M | $9M | · | $9M | $8M | $8M | $8M | $10M | $9M | |
| Common Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $7.0K | $5.0K | $5.0K | · | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $169M | $169M | $169M | $149M | $148M | $141M | $136M | $124M | $122M | · | $116M | $101M | $98M | $86M | $84M | $83M | |
| Retained Earnings | $-151M | $-146M | $-141M | $-136M | $-132M | $-127M | $-122M | $-115M | $-108M | · | $-91M | $-84M | $-76M | $-69M | $-61M | $-53M | |
| Stockholders' Equity | $18M | $23M | $28M | $13M | $15M | $14M | $14M | $9M | $14M | $18M | $25M | $18M | $22M | $17M | $23M | $30M | |
| Liabilities + Equity | $22M | $26M | $32M | $17M | $19M | $20M | $21M | $16M | $22M | · | $34M | $26M | $30M | $25M | $33M | $38M | |
| Shares Outstanding | 9,853,121 | 9,847,089 | 9,766,132 | 4,589,196 | 4,078,139 | 81,258,763 | 2,416,066 | 46,786,948 | 46,434,656 | · | 43,287,325 | 31,975,929 | 30,606,119 | 24,960,869 | 24,545,157 | 24,502,157 |
Nakit Akışı 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $352.0K | $401.0K | $711.0K | $692.0K | $955.0K | $831.0K | $825.0K | $2M | $1M | $1M | $1M | $1M | $1M | $859.0K | $922.0K | $897.0K | |
| Operating Cash Flow | $-4M | $-5M | $-2M | $-4M | $-4M | $-3M | $-4M | $-6M | $-6M | $-8M | $-5M | $-6M | $-5M | $-7M | $-8M | $-6M | |
| CapEx | · | · | · | $0 | $0 | $0 | · | $0 | $21.0K | $50.0K | · | $0 | $36.0K | $371.0K | · | $39.0K | |
| Investing Cash Flow | $-233.0K | $-9.0K | $0 | $0 | $0 | $0 | $-33.0K | $0 | $-83.0K | $-71.0K | $-72.0K | $-77.0K | $-22.0K | $-429.0K | $-1M | $-2M | |
| Stock Issued | $0 | $0 | $102.0K | $1M | $4M | $4M | $4M | $-4M | $4M | $0 | $63.0K | $2M | $12M | $722.0K | $9M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $4M | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-51.0K | $-195.0K | $18M | $989.0K | $5M | $4M | $11M | $-105.0K | $3M | $-277.0K | $13M | $2M | $11M | $547.0K | $-253.0K | $9M | |
| Net Change in Cash | $-4M | $-5M | $16M | $-3M | $1M | $771.0K | $7M | $-6M | $-3M | $-8M | $8M | $-4M | $6M | $-7M | $-9M | $2M | |
| Free Cash Flow | · | · | · | · | · | $-3M | · | · | · | $-8M | · | · | · | $-8M | · | · |
Kârlılık 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -23.3% | -22.1% | · | -23.5% | -24.3% | -24.9% | · | -33.6% | -33.1% | · | · | -22.2% | -25.4% | -24.6% | · | -17.3% | |
| ROE | -28.5% | -27.8% | · | -35.4% | -35.3% | -35.4% | · | -53.8% | -48.7% | -49.9% | · | -30.3% | -31.9% | -30.3% | · | -20.4% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.2 | 10.5 | · | 6.9 | 7.0 | 4.3 | · | 1.8 | 2.7 | · | · | 3.5 | 5.1 | 3.8 | · | 6.1 | |
| Quick Ratio | 8.0 | 10.2 | · | 6.3 | 6.8 | 4.0 | · | 1.1 | 2.1 | · | · | 2.7 | 4.5 | 2.9 | · | 5.6 |
Değerleme (TTM) 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-20M | · | $-22M | $-26M | $-30M | · | $-31M | $-32M | $-31M | · | $-30M | $-30M | $-28M | · | $-24M | |
| Market Cap | $14M | $15M | · | $10M | $9M | $405M | · | $379M | $1.18B | · | · | $998M | $1.41B | $973M | · | $1.48B | |
| P/E | -0.5 | -0.3 | · | -0.3 | -0.2 | -0.5 | · | -0.8 | -4.1 | -35.4 | · | -27.4 | -35.8 | -28.9 | · | -46.6 | |
| P/B | 0.8 | 0.6 | · | 0.8 | 0.6 | 29.2 | · | 44.1 | 86.6 | · | · | 56.2 | 64.9 | 58.0 | · | 50.2 | |
| P / Tangible Book | 0.8 | 0.6 | · | 0.8 | 0.6 | 29.2 | · | 44.1 | 86.6 | · | · | 56.2 | 64.9 | 58.0 | · | 50.2 | |
| P / Cash Flow | · | -2.9 | · | · | · | -129.6 | · | · | · | · | · | · | · | -130.9 | · | · | |
| P / FCF | · | · | · | · | · | -129.6 | · | · | · | · | · | · | · | -124.6 | · | · | |
| Earnings Yield | -184.4% | -304.7% | · | -306.4% | -541.1% | -206.2% | · | -128.8% | -24.4% | -2.8% | · | -3.6% | -2.8% | -3.5% | · | -2.1% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-19M | $-30M | $-30M | $-29M | $-15M |
| Seyreltilmiş Hisse Başı Kâr | $-4.44 | $-17.05 | $-1.00 | $-1.36 | $-1.47 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 8.8 | — | 4.6 | 3.8 | 17.3 |
| Cari Oran | 8.6 | — | 3.9 | 3.1 | 16.4 |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 23 dosya · $5.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 3 (-1 önceki Ç'ye göre) | 1 (-3 önceki Ç'ye göre) | 5 (+3 önceki Ç'ye göre) | 1 (-4 önceki Ç'ye göre) | +130K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | $1.331.490 | 944.319 | 24,50% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $1.289.489 | 914.531 | 23,73% | Hisse senetleri |
| 683 Capital Management, LLC | $1.021.738 | 724.637 | 18,80% | Hisse senetleri |
| Stonepine Capital Management, LLC | $980.355 | 695.287 | 18,04% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $126.544 | 88.865 | 2,33% | Hisse senetleri |
| BIOS Capital Management, LP | $114.149 | 80.957 | 2,10% | Hisse senetleri |
| CITADEL ADVISORS LLC | $88.908 | 63.055 | 1,64% | Hisse senetleri |
| OPPENHEIMER & CO INC | $88.889 | 63.042 | 1,64% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $85.677 | 60.762 | 1,58% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $85.061 | 36.351 | 1,57% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $62.044 | 43.570 | 1,14% | Hisse senetleri |
| CAPTRUST FINANCIAL ADVISORS | $46.946 | 33.295 | 0,86% | Hisse senetleri |
| Texas Capital Bank Wealth Management Services Inc | $34.412 | 24.406 | 0,63% | Hisse senetleri |
| NORTHERN TRUST CORP | $30.645 | 21.734 | 0,56% | Hisse senetleri |
| VANGUARD GROUP INC | $20.763 | 8.873 | 0,38% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $17.061 | 12.100 | 0,31% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $5.271 | 3.738 | 0,10% | Hisse senetleri |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $3.927 | 2.785 | 0,07% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $1.044 | 768 | 0,02% | Hisse senetleri |
| BlackRock, Inc. | $118 | 84 | 0,00% | Hisse senetleri |
| Rockefeller Capital Management L.P. | $117 | 83 | 0,00% | Hisse senetleri |
| BARCLAYS PLC | $39 | 28 | 0,00% | Hisse senetleri |
| UBS Group AG | $1 | 1 | 0,00% | Hisse senetleri |
Şirket yöneticileri 12 içeriden öğrenenler · 5 yöneticiler · 8 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| William Tai-Wei Ho | President and CEO | 13 Aralık 2023 A | 2.421.512 | 0 | 0 | $0 |
| McCall Patrick | Chief Financial Officer | 13 Aralık 2023 A | 26.755 | 0 | 0 | $0 |
| Kate Rochlin | Chief Operating Officer | 13 Aralık 2023 A | 17.558 | 0 | 0 | $0 |
| Trishna Goswami | Chief Medical Officer | 13 Aralık 2023 A | 6.729 | 0 | 0 | $0 |
| Lawrence Lamb | EVP and CSO | 13 Aralık 2023 A | 101.369 | 0 | 0 | $0 |
| Jeremy R. Graff | Yönetim kurulu üyesi | 13 Aralık 2023 A | 4.549 | 0 | 0 | $0 |
| Corinne Epperly | Yönetim kurulu üyesi | 13 Aralık 2023 A | 81.967 | 0 | 0 | $0 |
| Alan S. Roemer | Yönetim kurulu üyesi | 13 Aralık 2023 A | 158.448 | 0 | 0 | $0 |
| Peter C. Brandt | Yönetim kurulu üyesi | 13 Aralık 2023 A | 264.440 | 0 | 0 | $0 |
| EMILY FAIRBAIRN | Yönetim kurulu üyesi | 28 Temmuz 2023 J | 0 | 0 | 0 | $0 |
| Luba Greenwood | Yönetim kurulu üyesi | 15 Haziran 2023 A | 7.826 | 0 | 0 | $0 |
| Travis Whitfill | Yönetim kurulu üyesi | 15 Haziran 2023 A | — | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| EMILY FAIRBAIRN, Malcom Fairbairn, Malcom and Emily Fairbairn 2010 CRUT ×2 başvurular | 29 Mayıs 2026 | 2,20% | Değişiklik | — | SEC |
| BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III QP, LP, BIOS Fund III NT, LP, Bios Clinical Opportunity Fund, LP, BP Directors, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Bios Equity COF, LP, Cavu Management, LP, BIOS Capital Management, LP, Cavu Advisors, LLC, BIOS Advisors GP, LLC, Kreis Leslie W., Fletcher Aaron G.L. ×5 başvurular | 29 Aralık 2025 | 2,90% | Değişiklik | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.